Beijing Konruns Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 720.04 million compared to CNY 587.99 million a year ago. Revenue was CNY 720.04 million compared to CNY 587.99 million a year ago.

Net income was CNY 148.63 million compared to CNY 103.67 million a year ago. Basic earnings per share from continuing operations was CNY 0.9498 compared to CNY 0.6625 a year ago. Diluted earnings per share from continuing operations was CNY 0.9498 compared to CNY 0.6625 a year ago.